QUAY STEVEN C 4
4 · ATOSSA THERAPEUTICS, INC. · Filed Jul 1, 2024
Insider Transaction Report
Form 4
QUAY STEVEN C
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2024-06-27+1,795,100→ 1,795,100 totalExercise: $1.05Exp: 2034-06-27→ Common Stock (1,795,100 underlying)
Footnotes (1)
- [F1]The options shall vest on a quarterly basis over 24 months following June 27, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024, with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024.